Keiko Fukino

TCT-27 The Impact of Second Generation Drug-eluting Stent on Mid-term Clinical Outcome in Patients with Unprotected Left Main, Milan and New-Tokyo Registry

Niels R. Holm, Kari Kervinen, Matti J. Niemela, Andrejs Erglis, Indulis Kumsars, Terje Steigen, Evald H. Christiansen, Markku Eskola, Hannu Romppanen, Andis Dombrovskis, Ole Frobert, Lars Åberge, Pål Gunnes, Juhani Airaksinen, Anders Hervold, Sanda Jegere, Thor Trovik, Lisette Okkels Jensen, Michael Maeng, Timo Makikallio, Mikko Pietila, Iwar Sjögren, Per Thayssen, Saila Vikman, Jens F. Lassen, Leif Thuesen Aarhus University Hospital, Skejby, Aarhus N, Denmark, Oulo University Hospital, Oulo, Finland, University of Oulo, Oulo, Finland, Pauls Stradins Clinical University Hospital, Riga, Latvia, Latvian Cardiology Center, Riga, Latvia, University Hospital of Northern Norway, Tromso, Norway, Department of Cardiology, Aarhus University Hospital, Skejby, Aarhus N, Denmark, Tampere Heart Center, Tampere, Finland, Latvian center of cardiology, Paul Stradins Clinical Hospital, Riga, Latvia, Örebro University Hospital, Örebro, Sweden, Rikshospitalet, Oslo, Norway, Feiringklinikken, Feiring, Norway, Turku University Hospital, Turku, Finland, Pauls Stradins Clinical University Hospital, Riga, Not applicable, University Hospital of Tromsoe, Tromsoe, Norway, Odense University Hospital, Odense, Denmark, Aarhus University Hospital, Aarhus, Denmark, Falun Hospital, Falun, Sweden, Department of Cardiology, Odense University Hospital, Odense, Denmark, Tampere University Hospital, Tampere, Finland, Department of Cardiology, Aarhus University Hospital, Skejby, Denmark, Aarhus, Denmark